Lexogen is a transcriptomics and Next Generation Sequencing (NGS) company, focusing on the development of technologies for complete transcriptome sequencing and providing RNA-Seq services.
View company profile
The portfolio includes library preparation kits for whole transcriptome, expression profiling (for wide range of sample types, including blood), and small RNA sequencing, full-length cDNA amplification, RNA extraction, ribosomal RNA depletion, poly(A) RNA selection kits, spike-in RNA variant control mixes, metabolic RNA labeling modules, and RNA-Seq data analysis software. Lexogen is based at Vienna BioCenter in Austria and has a subsidiary in the US. To learn more, visit www.lexogen.com and follow @lexogen.